EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies
"Creating manufacturing innovations" so as to deliver affordable next generation advanced therapies.
The EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, hosted at University College London, provides an international lead in improving the way in which new biomolecules and processes are developed for manufacture and delivery to the patient. The Centre acts as the focus for a National and International network of leading users and academics in biopharmaceutical manufacturing and provides strong support for UK industry.
The Centre aims to reduce greatly the time and costs of developing new treatments and to improve access to protein drugs with advanced therapeutic properties. The developments offer the potential for a step change in the competitiveness and performance of the UK-based biopharmaceutical sector.
Our flagship research projects are directed to developing techniques to assess the manufacturability of new biopharmaceuticals very early in the development process while new decisional tools will aid the definition of the process sequence and help optimise the cost of goods and facility fit for new products.
We are always interested in discussing new opportunities for research collaboration.
EPSRC Centre Director
Professor Nigel Titchener-Hooker
Page last modified on 25 mar 14 12:05